Pieter Van Brantegem

7PUBLICATIONS
56CO-AUTHORS
PharmacogenomicsMedical virologyMedical infection agents (incl. prions)GlycoconjugatesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 24, 2026
Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials.

|Mar 06, 2026
Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.

Eunsol Yang, Pieter Van Brantegem, Charles A Peloquin

|May 20, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification.

Suzanne M Dufault, Geraint R Davies, Elin M Svensson

|Sep 28, 2021
Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid.

Ruth Van Daele, Joost Wauters, Pieter De Cock

|Apr 27, 2020
Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry.

Bing Qi, Matthias Gijsen, Pieter Van Brantegem

|Oct 08, 2019
Current insights in the complexities underlying drug-induced cholestasis.

Neel Deferm, Tom De Vocht, Bing Qi

Pageof 2

Frequent Collaborators

4 joint publications

Pieter Annaert

3 joint publications

Bing Qi

3 joint publications

Tom De Vocht

3 joint publications

Neel Deferm